C2N Diagnostics, LLC ("C2N"), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, highlighted ...
Energean (LON:ENOG) executives used the company’s full-year 2025 results call to address the impact of the escalating ...
BACKGROUND: Premature atrial contractions (PACs) are independently associated with atrial fibrillation, stroke, and heart failure, yet no pharmacological therapy is approved for PAC suppression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results